You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Blood Diseases

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Prognostic Indices

Recruiting
  • Multiple Myeloma
  • Hematologic Diseases
  • blood viscosity , albumin / fibrinogen ratio and red cell distribution
  • Assiut, Egypt
    Assiut University hospital
Oct 17, 2023

Relapsed or Refractory Multiple Myeloma Trial in Tianjin (YTS104 Cells injection)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • YTS104 Cells injection
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

Severe Aplastic Anemia Trial in Tianjin (avatrombopag)

Recruiting
  • Severe Aplastic Anemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Feb 7, 2023

AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • CD33/CLL1 dual CAR-NK cell
  • +5 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 4, 2023

Coagulation, Inflammation and Vessels in Chronic Liver Disease

Not yet recruiting
  • Chronic Liver Diseases
  • Coagulation
  • biomarker assay
  • (no location specified)
May 9, 2023

Mitochondrial DNA in Vitreous Fluid and Blood in Eye Disease or

Withdrawn
  • Eye Diseases
  • +5 more
  • Sample collection from tissue discard
  • (no location specified)
Jan 30, 2023

Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases

Recruiting
  • Autoimmune Diseases
  • +2 more
  • Blood collection
  • Paris, France
    Département de Médecine Interne et Immunologie Clinique (DMIIC),
Dec 15, 2022

Lymphatic Diseases, Hematopoietic Malignancy Trial in Minneapolis (Umbilical Cord Blood (UCB))

Recruiting
  • Lymphatic Diseases
  • Hematopoietic Malignancy
  • Umbilical Cord Blood (UCB)
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

Marginal Zone Lymphoma Trial in Tianjin (Obinutuzumab, lenalidomide)

Recruiting
  • Marginal Zone Lymphoma
  • Obinutuzumab, lenalidomide
  • Tianjin, Tian, China
    Institute of Hematology & Blood Diseases Hospital
Apr 27, 2023

Multiple Myeloma, Lymphoma Trial in China (Etoposide, Cyclophosphamide, Mecapegfilgrastim, day 2)

Recruiting
  • Multiple Myeloma
  • Lymphoma
  • Hefei, Anhui, China
  • +6 more
Dec 1, 2022

Spinal Cord Injuries, Spinal Cord Diseases, Trauma, Nervous System Trial in West Orange (Orthostatic challenge, Biostim-5

Not yet recruiting
  • Spinal Cord Injuries
  • +9 more
  • Orthostatic challenge
  • +3 more
  • West Orange, New Jersey
    Kessler Foundation
Feb 8, 2023

SRMA of the Effect of Soy Protein on Blood Pressure

Active, not recruiting
  • Blood Pressure
  • Cardiovascular Diseases
  • Soy protein
  • Toronto, Ontario, Canada
    Clinical Nutrition and Risk Factor Modification Centre, St. Mich
Nov 28, 2022

Coronary Artery Disease, Valvular Heart Disease Trial in Halifax (All-blood cardioplegia, Standard cardioplegia)

Completed
  • Coronary Artery Disease
  • Valvular Heart Disease
  • All-blood cardioplegia
  • Standard cardioplegia
  • Halifax, Nova Scotia, Canada
    Capital Health
Oct 26, 2022

AML, Adult Trial in Tianjin (QN-023a, Cyclophosphamid, Fludarabine)

Recruiting
  • AML, Adult
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022

Minimal Residual Disease Trial in Tianjin (QN-030a, Cyclophosphamid, Fludarabine)

Recruiting
  • Minimal Residual Disease
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Nov 3, 2022

Heart Valve Diseases Trial in Dokki (Power breath plus, Incrementing the training load, Diaphragmatic breathing exercises)

Completed
  • Heart Valve Diseases
  • Power breath plus
  • +2 more
  • Dokki, Egypt
    Outpatient clinic faculty of physical therapy cairo university
Aug 23, 2023

Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

Not yet recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Obinutuzumab Injection [Gazyva]
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023

Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

Not yet recruiting
  • Relapsed/Refractory Chronic Lymphocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023

National Longitudinal Cohort of Hematological Diseases

Recruiting
  • Multiple Myeloma
  • +17 more
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jan 11, 2022

    Cord Trial in Jinan (Intravenous infusion of cord blood mononuclear cells, application of granulocyte stimulating factor)

    Recruiting
    • Cord
    • Intravenous infusion of cord blood mononuclear cells
    • application of granulocyte stimulating factor
    • Jinan, Shandong, China
      Pediatrics, Qianfoshan Hospital
    Nov 25, 2022

    Transplant-Related Disorder Trial in Tianjin (Ruxolitinib)

    Recruiting
    • Transplant-Related Disorder
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jan 28, 2023

    Relapsed or Refractory Multiple Myeloma Trial in Tianjin (QLS32015)

    Recruiting
    • Relapsed or Refractory Multiple Myeloma
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jun 24, 2023

    Blood Specimen Collection For Laboratory Assay Research

    Recruiting
    • General; Metabolic Disorder
    • +3 more
      • San Francisco, California
        Roman Health Ventures Study Site
      Sep 13, 2023

      Certain Diseases Involving Blood Vessels

      Recruiting
      • Sickle Cell Disease
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

        Recruiting
        • Myelodysplastic Syndromes
        • Chronic Myelomonocytic Leukemia
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital, Chinese Acade
        Jul 30, 2023